Correlation between serum cytokeratin 19 fragment and tissue polypeptide antigen levels in patients with non-malignant diseases

被引:8
作者
Kashiwabara, K [1 ]
Nakamura, H [1 ]
Kiguchi, T [1 ]
Matsuoka, T [1 ]
机构
[1] Tokyo Med Coll, Dept Internal Med 5, Ami, Ibaraki 30003, Japan
关键词
tumor marker; non-insulin-dependent diabetes mellitus; liver cirrhosis; hemodialysis; aspartate aminotransferase; alanine aminotransferase;
D O I
10.1016/S0009-8981(98)00026-6
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
It has been reported that cytokeratin 19 fragment (CYFRA 21-1) is superior to tissue polypeptide antigen (TPA) as a tumor marker, although there is a high correlation between CYFRA 21-1 and TPA levels in patients with lung cancer. We investigated correlations between these tumor markers in patients with non-malignant diseases. Marked correlations were found between CYFRA 21-1 and TPA levels in healthy subjects (n = 31), non-insulin-dependent diabetes mellitus (n = 160) and hemodialysis patients (n = 83) (range of r-value = 0.90-0.93, P < 0.0001). However in liver cirrhosis patients (n = 36), only a weak correlation was found (r=0.39, P < 0.0001) and there were correlations between only TPA and both aspartate aminotransferase and alanine aminotransferase levels (r(2) = 0.48 and 0.36, P < 0.0001). The elevated TPA levels in liver cirrhosis patients may be related to the decreased specificity of TPA as a tumor marker. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:35 / 42
页数:8
相关论文
共 18 条
  • [1] ANTIGENICITY OF POOLED HUMAN MALIGNANT AND NORMAL TISSUES BY CYTO-IMMUNOLOGICAL TECHNIQUE - PRESENCE OF AN INSOLUBLE, HEAT-LABILE TUMOR ANTIGEN
    BJORKLUND, B
    BJORKLUND, V
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1957, 10 (03): : 153 - 184
  • [2] Bodenmueller Heinz, 1994, International Journal of Biological Markers, V9, P70
  • [3] BROERS JLV, 1988, CANCER RES, V48, P3221
  • [4] A CLINICAL AND LABORATORY EVALUATION OF THE BEHAVIOR OF TISSUE POLYPEPTIDE ANTIGEN IN LIVER-CIRRHOSIS
    COLLAZOS, J
    GENOLLA, J
    RUIBAL, A
    [J]. DIGESTION, 1992, 53 (3-4) : 157 - 161
  • [5] KEW MC, 1986, CANCER, V58, P127, DOI 10.1002/1097-0142(19860701)58:1<127::AID-CNCR2820580122>3.0.CO
  • [6] 2-W
  • [7] LEANDRO G, 1990, HEPATO-GASTROENTEROL, V37, P449
  • [8] STUDY OF A NEW TUMOR-MARKER, CYFRA-21-1, IN MALIGNANT AND NONMALIGNANT DISEASES
    MOLINA, R
    AGUSTI, C
    FILELLA, X
    JO, J
    JOSEPH, J
    GIMENEZ, N
    BALLESTA, AM
    [J]. TUMOR BIOLOGY, 1994, 15 (06) : 318 - 325
  • [9] THE CATALOG OF HUMAN CYTOKERATINS - PATTERNS OF EXPRESSION IN NORMAL EPITHELIA, TUMORS AND CULTURED-CELLS
    MOLL, R
    FRANKE, WW
    SCHILLER, DL
    GEIGER, B
    KREPLER, R
    [J]. CELL, 1982, 31 (01) : 11 - 24
  • [10] DETERMINATION OF TISSUE POLYPEPTIDE ANTIGEN (TPA) LEVELS IN DIFFERENT CANCER TYPES AND CONTROLS
    MROSS, KB
    WOLFRUM, DI
    RAUSCHECKER, H
    [J]. ONCOLOGY, 1985, 42 (05) : 288 - 295